news
Precision NanoSystems to host nanomedicines symposium
Join Precision NanoSystems for its second annual nanomedicines symposium...
List view / Grid view
Drug Delivery Systems
news
EU approval for Regeneron and Sanofi’s rheumatoid arthritis drug
The European Commission (EC) has granted marketing authorisation for Regeneron and Sanofi’s Kevzara (sarilumab) for the treatment of rheumatoid arthritis...
article
Formulation Development & Delivery In-Depth Focus
In this Formulation Development & Delivery In-Depth Focus: A report on the use of freeze-drying to develop orally disintegrating tablets; a review of mucosal drug delivery; an interview on drug delivery through the skin; and a profile of three analytical technologies used to develop drug delivery systems...
article
Scientific Poster Gallery 2017
In this supplement, we've brought together a collection of interesting posters from leading companies in order to celebrate cutting-edge research in the pharmaceutical industry and to share with our readers some of the varied work being carried out by their colleagues...
news
FDA approves cryopreserved formulation of ReNeuron’s candidate
The FDA has approved the cryopreserved formulation of ReNeuron’s human retinal progenitor cell (hRPC) therapeutic candidate...
news
Precision NanoSystems at the BIO International Convention 2017
A key session opens up the challenges of delivering personalized genetic medicines...
article
Analytical techniques for faster development of drug delivery systems
The challenge of efficiently delivering a drug to its site of action, while maintaining its efficacy and minimising its potential toxicity, has received much attention in recent years, with the growing use of complex and often delicate biological molecules as therapeutic agents...
news
Injectable drug delivery market worth US$624.50 billion by 2021
23 March 2017 | By Niamh Marriott, Junior Editor
According to a new report, the global injectable drug delivery market is projected to reach US$624.50 Billion by 2021 from US$362.38 billion in 2016...
article
Improving the consistency of MDI drug delivery
A defining characteristic of inhaled drug delivery is variability in the dose received by the patient, as a result of physiology, for example, or the technique applied during use. This variability directly affects clinical outcomes so reducing it to a minimum is an important goal for the industry...
article
Understanding the effect of API changes in pharmaceutical processing
For the pharmaceutical scientist, the journey of an active molecule from the end of its synthetic pathway and crystallisation to its ultimate site of action is a fascinating one, and one that is necessary to understand...
article
Issue #1 2017 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
article
Spray drying – various challenges, one solution?
Spray drying is a proven, flexible and scalable process used within the pharmaceutical industry to address a wide range of formulation and drug delivery challenges. Its versatility has been proven through applications to both small chemical and biopharmaceutical drugs for product delivery via multiple routes of administration.
article
Osteomyelitis: How artificial bone grafts are filling the gap
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
We caught up with Bonesupport's CEO Richard Davies to find out how they're using artificial bone grafts to help sufferers of chronic osteomyelitis...
article
Issue #4 2016 – Digital edition
In this issue: Regulation, Environmental Monitoring, Drug Delivery; Microbiology, Track & race, Spectroscopy, HPLC, Mass Spectrometry, and much more...
news
Quotient Clinical hosts formulation development and drug delivery seminar series
15 June 2016 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, is holding a series of formulation development and drug delivery seminars this June and July...
